PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,985,000 | +6.9% | 79,997 | +38.2% | 0.07% | -9.8% |
Q4 2021 | $1,857,000 | -2.6% | 57,897 | +9.2% | 0.08% | -11.8% |
Q3 2021 | $1,907,000 | +296.5% | 53,008 | +386.4% | 0.09% | +322.7% |
Q2 2021 | $481,000 | -77.6% | 10,899 | -65.0% | 0.02% | -87.4% |
Q4 2020 | $2,152,000 | – | 31,180 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |